KemPharm Rebrands to Zevra, Focused on Advancing Rare Disease Therapeutics

In February 2023, KemPharm, a rare disease therapeutics company, changed its name to Zevra Therapeutics. They adopted the zebra—a global symbol for rare diseases—to show their commitment to creating a profound impact on the lives of patients battling these complex conditions. Zevra has secured both ZevraTherapeutics.com and Zevra.com as part of their domain strategy. A short .com domain helps with online brand visibility and opens up more opportunities for the company's growth and outreach.